|
Franklin India Medium To Long Duration Fund As on April 30, 2025 |
|
|
An open ended medium term debt scheme investing in instruments such that the Macaulay duration of the portfolio is between 4 years to 7 years. Portfolio Macaulay duration under anticipated adverse situation is 1 year to 7 years.
SCHEME CATEGORY
Medium to Long Duration
SCHEME CHARACTERISTICS
100% in Debt, Money Market instruments, cash & cash equivalent including government securities.
INVESTMENT OBJECTIVE
The investment objective of the scheme is to generate returns by investing in debt and money market instruments such that the Macaulay duration of the scheme portfolio is between 4 to 7 years.
DATE OF ALLOTMENT:
| September 24, 2024 |
Anuj Tagra & Chandni Gupta
BENCHMARK:
CRISIL Medium to Long Duration Debt A-III Index
| RESIDUAL MATURITY / AVERAGE MATURITY | 11.98 Years |
| ANNUALISED PORTFOLIO YTM# | 6.81%*** |
| MODIFIED DURATION | 6.50 Years |
| MACAULAY DURATION | 6.73 Years |
***Yield to maturity (YTM) of the portfolio is calculated by recomputing yield from simple average of valuation prices provided by valuation agencies for G-sec FRB securities.
EXPENSE RATIO#: 0.76% EXPENSE RATIO# (DIRECT) : 0.30%
| # The above ratio includes the GST on Investment Management Fees. The rates specified are the actual expenses charged as at the end of the month. The above ratio also includes, proportionate charge in respect sales beyond T-30 cities subject to maximum of 30 bps on daily net assets, wherever applicable. |
EXISTING INVESTORS
Rs5000/1 MINIMUM INVESTMENT FOR SIP
Rs 500/1
ADDITIONAL INVESTMENT/MULTIPLES
FOR EXISTING INVESTORS
Rs1000/1 LOAD STRUCTURE:
| Entry Load | : | Nil |
| Exit Load (for each purchase of Units) | : | Nil |
| Different plans have a different expense structure |
| Growth Plan | Rs 10.6209 |
| IDCW Plan | Rs 10.6209 |
| Direct - Growth Plan | Rs 10.6539 |
| Direct - IDCW Plan | Rs 10.6539 |
As per the addendum dated March 31, 2021, the Dividend Plan has been renamed to Income Distribution cum capital withdrawal (IDCW) Plan with effect from April 1, 2021 | |
| FUND SIZE (AUM) | |
| Month End | Rs 51.52 Crores |
| Monthly Average | Rs 50.16 Crores |
| Company Name | Company Ratings | Market Value (including accrued interest, if any) (Rs. in Lakhs) | % of assets |
| Mankind Pharma Ltd* | CRISIL AA+ | 509.21 | 9.88 |
| Total Corporate Debt | 509.21 | 9.88 | |
| 7.10% West Bengal SDL (26-Mar-2047)* | SOVEREIGN | 519.76 | 10.09 |
| 7.10% Kerala SDL (26-Mar-2043)* | SOVEREIGN | 519.30 | 10.08 |
| 7.10% West Bengal SDL (26-Mar-2046)* | SOVEREIGN | 518.85 | 10.07 |
| 7.10% West Bengal SDL (26-Mar-2045)* | SOVEREIGN | 517.38 | 10.04 |
| GOI FRB 2034 (30-OCT-2034)* | SOVEREIGN | 406.28 | 7.89 |
| 7.15% Tamil Nadu SDL (22-Jan-2035)* | SOVEREIGN | 373.86 | 7.26 |
| 8.42% Andhra Pradesh SDL (08-Aug-2029)* | SOVEREIGN | 327.10 | 6.35 |
| 7.14% Jammu & Kashmir SDL (29-Dec-2036)* | SOVEREIGN | 303.72 | 5.89 |
| 7.77% Haryana SDL (10-Jan-2036)* | SOVEREIGN | 255.72 | 4.96 |
| 7.08% Kerala SDL (26-Mar-2040) | SOVEREIGN | 216.69 | 4.21 |
| Total Gilts | 3,958.67 | 76.83 | |
| Total Debt Holdings | 4,467.88 | 86.71 | |
| Company Name | No.of Shares | Market Value(Rs. in Lakhs) | % of Assets |
| Alternative Investment Fund Units | |||
| Corporate Debt Market Development Fund Class A2 | 124 | 13.75 | 0.27 |
| Total Alternative Investment Fund Units | 13.75 | 0.27 | |
| Total Holdings | 4,481.62 | 86.98 | |
| Call,cash and other current asset | 670.79 | 13.02 | |
| Total Asset | 5,152.42 | 100.00 | |
@ TREPs /Reverse Repo : 9.92%, Others (Cash/ Subscription receivable/ Redemption payable/ Receivables on sale/Payable on Purchase/ Other Receivable / Other Payable) : 3.10%
All investments in debt funds are subject to various types of risks including credit risk, interest rate risk, liquidity risk etc. Some fixed income schemes may have a higher
concentration to securities rated below AA and therefore may be exposed to relatively higher risk of downgrade or default and the associated volatility in prices which
could impact NAV of the scheme. Credit rating issued by SEBI registered entities is an opinion of the rating agency and should not be considered as an assurance of
repayment by issuer. There is no assurance or guarantee of principal or returns in any of the mutual fund scheme.
This scheme has exposure to floating rate instruments . The duration of these instruments is linked to the interest rate reset period. The interest rate risk in a floating rate
instrument or in a fixed rate instrument hedged with derivatives is likely to be lesser than that in an equivalent maturity fixed rate instrument. Under some market
circumstances the volatility may be of an order greater than what may ordinarily be expected considering only its duration. Hence investors are recommended to
consider the unadjusted portfolio maturity of the scheme as well and exercise adequate due diligence when deciding to make their investments.